1WA
VRTX icon

180 Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

180 Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
548
-27
-5% -$12K 0.03% 403
2026
Q1 		$257K Hold
575
– – 0.03% 392
2025
Q4 		$261K Buy
+575
New +$248K 0.03% 391
2025
Q2 		– Sell
-462
Closed -$224K – 438
2025
Q1 		$224K Buy
+462
New +$215K 0.04% 359
2024
Q4 		– Sell
-912
Closed -$424K – 467
2024
Q3 		$424K Sell
912
-45
-5% -$21.6K 0.07% 255
2024
Q2 		$471K Sell
957
-19
-2% -$8.25K 0.08% 229
2024
Q1 		$408K Buy
976
+293
+43% +$124K 0.07% 236
2023
Q4 		$281K Hold
683
– – 0.06% 294
2023
Q3 		$237K Buy
683
+2
+0.3% +$699 0.05% 299
2023
Q2 		$237K Sell
681
-101
-13% -$34K 0.05% 300
2023
Q1 		$246K Buy
782
+87
+13% +$26.1K 0.06% 299
2022
Q4 		$223K Buy
+695
New +$212K 0.05% 319
2022
Q3 		– Sell
-727
Closed -$209K – 388
2022
Q2 		$209K Sell
727
-302
-29% -$80.8K 0.05% 329
2022
Q1 		$291K Sell
1,029
-45
-4% -$10.7K 0.06% 283
2021
Q4 		$245K Sell
1,074
-222
-17% -$43.2K 0.06% 306
2021
Q3 		$236K Buy
1,296
+10
+0.8% +$1.95K 0.05% 328
2021
Q2 		$253K Buy
1,286
+33
+3% +$6.9K 0.06% 306
2021
Q1 		$267K Buy
1,253
+13
+1% +$2.85K 0.07% 285
2020
Q4 		$288K Buy
1,240
+184
+17% +$42.2K 0.08% 233
2020
Q3 		$227K Buy
1,056
+367
+53% +$101K 0.09% 230
2020
Q2 		$203K Buy
+689
New +$187K 0.08% 248

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

180 Wealth Advisors's VRTX Position: Q2 2026 in Review

180 Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q2 2026, selling an estimated $12K and leaving 548 shares worth $272K. The position accounts for 0.03% of the portfolio, ranked #403.

180 Wealth Advisors first reported a position in VRTX in Q2 2020 and has held it in 21 quarters since. The position peaked at $471K in Q2 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • 180 Wealth Advisors held 548 shares of Vertex Pharmaceuticals worth $272K as of Q2 2026.
  • 180 Wealth Advisors sold 27 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12K.
  • Vertex Pharmaceuticals made up 0.03% of 180 Wealth Advisors's portfolio in Q2 2026, its #403 holding.
  • 180 Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • 180 Wealth Advisors's Vertex Pharmaceuticals position peaked at $471K in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.